Tonix Pharmaceuticals Holding Corp (TNXP)
0.2042
+0.01
(+7.47%)
USD |
NASDAQ |
Nov 21, 16:00
0.2038
0.00 (0.00%)
Pre-Market: 09:18
Tonix Pharmaceuticals Debt to Equity Ratio: 0.1077 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1077 |
| June 30, 2024 | 0.2016 |
| March 31, 2024 | 0.083 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.0844 |
| September 30, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2023
0.2016
Maximum
Jun 2024
0.0953
Average
0.0844
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 1.303 |
| Geovax Labs Inc | 0.00 |
| Abbott Laboratories | 0.3764 |
| Amicus Therapeutics Inc | 2.178 |
| United Therapeutics Corp | 0.0656 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 94.99M |
| Total Liabilities (Quarterly) | 20.78M |
| Shareholders Equity (Quarterly) | 74.21M |
| Current Ratio | 3.329 |
| Net Debt Paydown Yield | -1.21% |